CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06931964
NCT06931964N/ACompleted

The Level of Frailty in Individuals Diagnosed With Primary Sarcopenia; Balance, Fall Risk and Impact on Kinesiophobia

Karabuk University·observational·Posted Apr 17, 2025·Updated Jul 16, 2025

In Brief

An observational study for Sarcopenia. Completed, enrolled 68 participants across 1 site.

Detailed Summary

Primary sarcopenia is a condition that occurs with the aging process and is characterized by symptoms such as decreased muscle mass, impaired muscle function and decreased physical strength. The decrease in muscle mass can lead to a decrease in physical strength, balance and mobility, making older people more prone to frailty and falls, which can lead to a fear of falling. Although there are few studies on sarcopenia in the literature, the level of frailty in sarcopenia is related to balance, falls risk and kinesiophobia in sarcopenia. Our aim in the study was to measure frailty in elderly individuals diagnosed with sarcopenia and to determine the level of frailty. to evaluate the effect of sarcopenia on fall risk, balance and kinesiophobia and to evaluate the effect of sarcopenia on fall risk, balance and kinesiophobia according to the results of the evaluation and new rehabilitation programs on frailty, falls, kinesiophobia and balance resulting from sarcopenia and to be the basic data for the programs to be created.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSarcopenia
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedApr 17, 2025
Enrollment StartJun 1, 2024
Primary CompletionMay 20, 2025
TodayJul 1, 2026
Enrollment to primary: 12 monthsPosted 1.2 years ago